Exelon

"The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission tomography (PET) imaging of the brain in adults being evaluated for Alzheimer's disease (AD) "...

Exelon

DRUG DESCRIPTION

EXELON (rivastigmine tartrate) is a reversible
cholinesterase inhibitor and is known chemically as
(S)-N-Ethyl-Nmethyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate
hydrogen-(2R,3R)-tartrate. Rivastigmine tartrate is commonly referred to in the
pharmacological literature as SDZ ENA 713 or ENA 713. It has an empirical
formula of C14H22N2O2 • C4H6O6
(hydrogen tartrate salt–hta salt) and a molecular weight of 400.43 (hta salt).
Rivastigmine tartrate is a white to off-white, fine crystalline powder that is
very soluble in water, soluble in ethanol and acetonitrile, slightly soluble in
n-octanol and very slightly soluble in ethyl acetate.

The distribution coefficient at 37°C in
n-octanol/phosphate buffer solution pH 7 is 3.0.

What are the precautions when taking rivastigmine tartrate (Exelon)?

Before taking rivastigmine, tell your doctor or pharmacist if you are allergic to it (including having a rash while using rivastigmine patches); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.